The potential diagnostic and therapeutic applications of exosomes in drug-induced liver injury. (1st February 2021)

• Record Type: Journal Article
• Authors: Zhao, Lanlan; Wang, Yuezhi; Zhang, Yu
• Is Part Of: Toxicology letters. Volume 337(2021)
• Page Start: 68
• Page End: 77
• Publication Date: 2021-02-01
• Subjects: Drug-induced liver injury -- Exosomes -- Biomarkers -- Therapeutic agents; Toxicology -- Periodicals; 363.179
• DOI: 10.1016/j.toxlet.2020.11.021
• Languages: English
• ISSNs: 0378-4274

Abstract

Abstract: Drug-induced liver injury (DILI) has gradually become a global public medical problem, which can be caused by more than 1000 currently available drugs. Unfortunately, the diagnosis and treatment of DILI are limited and imperfect. Exosomes can be secreted by a variety of cells and tissues in the body, rich in cell-type specific proteins, nucleic acids and lipids, which has been widely studied as an important intercellular communication vehicle in liver diseases. Emerging data suggest that circulating exosomes and their cargos can be used as minimally-invasive sources of potential molecular biomarkers for the early detection, monitoring and evaluation of DILI. Exosomes in the urine were also found to contain proteins or RNAs that were indicative of DILI. In addition, exosomes derived from mesenchymal stem cell or hepatocyte are considered potential therapeutic agents to promote liver regenerative responses, modulate inflammatory response and deduce hepatocytes apoptosis. Based on the current findings, we suggest the potential applications of exosomes as biomarkers and therapeutics for DILI.